Aug 9
|
Results: ACADIA Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
|
Aug 8
|
ACADIA Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats Expectations
|
Aug 8
|
US High Growth Tech Stocks To Watch In August 2025
|
Aug 7
|
Acadia Q2 Earnings Beat, Nuplazid & Daybue Sales Drive Revenue Growth
|
Aug 7
|
Exploring 3 High Growth Tech Stocks In The US Market
|
Aug 6
|
Acadia Pharmaceuticals (ACAD) Tops Q2 Earnings and Revenue Estimates
|
Aug 6
|
Acadia: Q2 Earnings Snapshot
|
Aug 6
|
Acadia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operating Overview
|
Aug 6
|
Exploring 3 High Growth Tech Stocks in the US Market
|
Aug 5
|
Acadia Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference
|
Aug 4
|
Acadia Pharmaceuticals Appoints Scott Cenci as Chief Information and Data Officer
|
Aug 1
|
GMAB vs. ACAD: Which Stock Is the Better Value Option?
|
Aug 1
|
High Growth US Tech Stocks To Watch In August 2025
|
Jul 31
|
Exploring US High Growth Tech Stocks For July 2025
|
Jul 31
|
High Growth Tech Stocks in the US for July 2025
|
Jul 30
|
Exploring US High Growth Tech Stocks For Potential Portfolio Expansion
|
Jul 23
|
Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2025
|
Jul 17
|
High Growth Tech Stocks In The US For July 2025
|
Jun 26
|
Acadia’s ‘very bullish’ sales forecast restores some confidence on Wall Street
|
Jun 25
|
Acadia Pharmaceuticals Hosts Inaugural R&D Day Showcasing Pipeline and Long-Term Value Drivers
|